US FDA Strategy On Abuse-Deterrent Opioids Needs Rethinking, Panelists Say

 
• By Sue Sutter
  
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers